Kayfanda ® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare liver condition, Alagille Syndrome E.U. marketing authorization for ...
“To have a new treatment option that has been shown to reduce the itch and improve sleep is a very positive development for the ALGS community.” ALGS is an inherited rare, genetic disorder ...